閾剁墝浼氬憳绗?span style="font-size:1.5em;color:#f21">2骞滁/div> 璁块棶閲廁 3451351 缃戝潃:antibody.cnreagent.com 鍦ㄧ嚎鐣欒█
浜у搧鎼滅储
鎶椾綋 >> 鍏朵粬鎶椾綋
G铔嬬櫧缁撳悎铔嬬櫧6浣撴姉浣掽/div>
G铔嬬櫧缁撳悎铔嬬櫧6浣撴姉浣撳浘鐗?></a></div>    <span style=
浜よ揣鏈烔 1鍛?/span>
绱㈠彇璧勬枡鍙婃姤浠饵/span>
浜よ揣鏈烔 1鍛?/td>
浜у搧鍒悕: 楦熻嫹閰哥粨鍚堣泲鐧?(GBP6)鎶椾綋
Anti-Gbp6
浜у搧浠嬬粛
闈舵爣锛欬p style="text-indent: 2em;">Gbp6


浜у搧鍒悕锛欬p style="text-indent: 2em;">AI595338锛 GBP-6锛 Mpa2l锛 Gbp6锛 guanylate binding protein 6锛 guanylate binding protein 6锛 guanylate-binding protein 6锛 guanylate binding protein 6锛 GTP-binding protein 6锛 guanine nucleotide-binding protein 6锛 macrophage activation 2 like锛 macrophage activation 2 like protein锛 G铔嬬櫧缁撳悎铔嬬櫧6浣擄紱 楦熻嫹閰哥粨鍚堣泲鐧?(GBP6)锛


鑳屾櫙淇℃伅锛欬div style="text-indent: 2em;">The guanylate-binding proteins (GBPs), a family of interferon-induced GTP-binding proteins function in innate immunity against microbial and viral pathogens. In humans, there are seven GBPs from hGBP1 to hGBP7. Human GBP1 and GBP2 have been shown to exhibit antiviral activity as well as being able to regulate the inhibition of proliferation and invasion of endothelial cells in response to interferon (IFN) (1,3). GBP6 is induced by IFN and hydrolyzes GTP to both GDP and GMP. The precise function of GBP6 is still under investigation .

瀹夸富锛歊bt
绫诲瀷锛歅ab
鍚岀鍨婜IgG
搴旂敤锛歐B
绾寲鏂瑰紡锛氫翰鍜岀函鍖朁br/>鍋惰仈鐗╋細Unconjugated
鎬х姸锛氭恫浣
瀛樺偍婧舵恫锛氬弬闃呰鏄庝功
娴撳害锛欱atch dependent (Please refer to the vial label for the specific concentration.)
绋€閲婃瘮渚婜 Optimal dilutions/concentrations should be determined by the end user
鍌ㄥ瓨锛氱粡甯镐娇鐢ㄥ垯4掳C淇濆瓨銆?20掳C淇濆瓨涓嶈秴杩囦袱骞淬€傞伩鍏嶅弽澶嶅喕铻嶃€侟br/>娉ㄦ剰浜嬮」锛氫粎渚涘疄楠屽浣跨敤銆備笉閫傜敤浜庝汉绫绘垨鍔ㄧ墿鐨勪换浣曚复搴婏紝娌荤枟鎴栬瘖鏂敤閫斻€備笉閫傚悎鍔ㄧ墿鎴栦汉绫婚鐢ㄣ€侟/p>

鐩稿叧浜у搧
Baidu
map